The cast of the North American Tour of "Spamalot." Nathaniel Mahone is all the way to the right in the yellow lapels.
In this week's second major AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, designed to accelerate drug discovery and support biology-related research work. The launch ...
Scottish journalist and lifelong sports fan who grew up in Edinburgh playing and following football (soccer), cricket, tennis, golf, hockey… Joined Diario AS in 2012, becoming Director of AS USA in ...
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...
OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as ‌the startup deepens its push into the life sciences field.
The GPT-Rosalind model builds on OpenAI’s newest internal models with enhanced tool use, database integration, and domain-specific knowledge. OpenAI is expanding into scientific research with the ...
OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine. The new tool, called GPT-Rosalind, is named after ...
Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine. pic.twitter.com ...
Shares of leading life sciences companies will be in focus on Friday after OpenAI launched GPT-Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. In ...
Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.
Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering.